Viswanathan Muthusamy

Also affiliated with Yale University, University of New Haven

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition”.

RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4291

N/A

0.920DataRank · unranked

19 citations

Dejian Zhao, Heather Lazowski, Man Li, Yuping Qian, Laura Abriola +8 more

Structure-Guided Identification of DNMT3B Inhibitors

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00011

N/A

0DataRank · unranked

20 citations

John C. Faver, Goran Micevic, Viswanathan Muthusamy, Shalley N. Kudalkar, Nicole Bertoletti +4 more

Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes

Cancer Research(2021)10.1158/0008-5472.can-20-4190

N/A

0DataRank · unranked

67 citations

Ioannis Vathiotis, Viswanathan Muthusamy, Patricia Gaule, Brandon M. Gassaway, David L. Rimm +2 more

Comprehensive Analysis of Metabolic Isozyme Targets in Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-3983

N/A

0DataRank · unranked

12 citations

Vignesh Gunasekharan, David Casadevall, Tao Qing, Julia Foldi, Raghav Sehgal +12 more

Data from Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes

(2023)10.1158/0008-5472.c.6512994.v1

N/A

0DataRank · unranked

0 citations

Ioannis Vathiotis, Viswanathan Muthusamy, Patricia Gaule, Brandon M. Gassaway, David L. Rimm +2 more